ARCHIVES

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

This article is from The Cancer Letter archive.

Vol. 31 No. 03 | January 21, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Contract Awards.

February 18, 2000

NCI Programs: NCI Drug Screening To Take More Targeted Approach; BSA Okays Plan To Support New MA Contracts

April 3, 1998

Abrams, Tomaszewski To Co-Direct DCTD

June 10, 2011

ASCO Picks Charles Balch To Succeed John Durant as Executive Vice President.

January 7, 2000

Senate Vote On Override Of NIH Reauthorization Veto Delayed Until After US-USSR Summit Meeting

November 22, 1985

DOD Breast Cancer Program Releases Research Solicitation

October 1, 1993